Skip to main content
. 2023 Aug 1;19(8):1495–1503. doi: 10.5664/jcsm.10616

Table 3.

Medication use outcomes at 3-month follow-up (n = 58).

Medication Use Outcomes at 3-Month Follow-Up n (%)
Use of BZD-related hypnotics
 No 37 (63.79)
 Yes 21 (36.21)
Use of any medication or substance for sleep
 No 17 (29.31)
 Yes 41 (70.69)

BZD = benzodiazepine.